ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Stomach Cancer
Colorectal Cancer
Esophageal Cancer
Prostatic Cancer

Adenocarcinoma trials near San Antonio, TX, USA:

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

This study will test the effectiveness (anti-tumor activity), safety, and ability to increase the body's immune system to fight pancreatic cancer by...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: Pembrolizumab
Drug: Defactinib

Phase 2

The University of Texas System (UT)
The University of Texas System (UT)

San Antonio, Texas, United States and 2 other locations

The goal of this clinical trial is to test an experimental treatment (immunotherapy) in pancreatic cancer patients. The main research objectives are:...

Enrolling
Pancreatic Ductal Adenocarcinoma
Drug: ATP150
Drug: Ezabenlimab

Phase 1

Amal Therapeutics

San Antonio, Texas, United States and 14 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 214 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Active, not recruiting
Pancreatic Cancer
Combination Product: TTX-030, nab-paclitaxel and gemcitabine
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

San Antonio, Texas, United States and 63 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Enrolling
Colorectal Adenocarcinoma
Ewing Sarcoma
Drug: Pemetrexed
Drug: INBRX-109

Phase 1

Inhibrx Biosciences, Inc

San Antonio, Texas, United States and 33 other locations

This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced...

Enrolling
Endometrial Adenocarcinoma
Appendiceal Adenocarcinoma
Drug: APL-5125

Phase 1, Phase 2

Apollo Therapeutics

San Antonio, Texas, United States and 8 other locations

Study CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic can...

Begins enrollment this month
Clear Cell Adenocarcinoma of Vulva
Clear Cell Adenocarcinoma of Fallopian Tube
Biological: Lorigerlimab

Phase 2

MacroGenics
MacroGenics

San Antonio, Texas, United States of America and 16 other locations

designed to examine the effects of AZD0171 and durvalumab in combination with standard-of-care chemotherapy in patients with pancreatic ductal adenocarcinoma...

Active, not recruiting
Locally Advanced or Metastatic Solid Tumours
Drug: Nab-paclitaxel
Drug: Durvalumab

Phase 2

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 33 other locations

a dose expansion phase to confirm the dose and combination with bevacizumab. Approximately 500 adult participants with NSCLC, gastroesophageal adenocarcinoma...

Active, not recruiting
Gastroesophageal Adenocarcinoma
Advanced Solid Tumors
Drug: ABBV-400
Drug: Trifluridine/Tipiracil

Phase 1

AbbVie
AbbVie

San Antonio, Texas, United States and 84 other locations

adenocarcinoma. Enrollment in the expansion cohorts is limited to the following tumor types: endometrial, SCCHN, CRC, and a basket cohort i...

Active, not recruiting
Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma
Drug: TPST-1495 twice daily
Drug: TPST-1495 once daily or on intermittent schedule

Phase 1

Tempest Therapeutics

San Antonio, Texas, United States of America and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems